These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 22874659

  • 21. Neuroimaging basis in the conversion of aMCI patients with APOE-ε4 to AD: study protocol of a prospective diagnostic trial.
    Chen GQ, Sheng C, Li YX, Yu Y, Wang XN, Sun Y, Li HY, Li XY, Xie YY, Han Y.
    BMC Neurol; 2016 May 12; 16():64. PubMed ID: 27176479
    [Abstract] [Full Text] [Related]

  • 22. Aβ-related memory decline in APOE ε4 noncarriers: Implications for Alzheimer disease.
    Lim YY, Laws SM, Villemagne VL, Pietrzak RH, Porter T, Ames D, Fowler C, Rainey-Smith S, Snyder PJ, Martins RN, Salvado O, Bourgeat P, Rowe CC, Masters CL, Maruff P.
    Neurology; 2016 Apr 26; 86(17):1635-42. PubMed ID: 27029632
    [Abstract] [Full Text] [Related]

  • 23. The neuroanatomical substrate of lexical-semantic decline in MCI APOE ε4 carriers and noncarriers.
    Venneri A, McGeown WJ, Biundo R, Mion M, Nichelli P, Shanks MF.
    Alzheimer Dis Assoc Disord; 2011 Apr 26; 25(3):230-41. PubMed ID: 21192234
    [Abstract] [Full Text] [Related]

  • 24. Synergistic effect of apolipoprotein E epsilon4 and butyrylcholinesterase K-variant on progression from mild cognitive impairment to Alzheimer's disease.
    Lane R, Feldman HH, Meyer J, He Y, Ferris SH, Nordberg A, Darreh-Shori T, Soininen H, Pirttilä T, Farlow MR, Sfikas N, Ballard C, Greig NH.
    Pharmacogenet Genomics; 2008 Apr 26; 18(4):289-98. PubMed ID: 18334913
    [Abstract] [Full Text] [Related]

  • 25. Effect of APOE ε4 allele on cortical thicknesses and volumes: the AddNeuroMed study.
    Liu Y, Paajanen T, Westman E, Wahlund LO, Simmons A, Tunnard C, Sobow T, Proitsi P, Powell J, Mecocci P, Tsolaki M, Vellas B, Muehlboeck S, Evans A, Spenger C, Lovestone S, Soininen H, AddNeuroMed Consortium.
    J Alzheimers Dis; 2010 Apr 26; 21(3):947-66. PubMed ID: 20693633
    [Abstract] [Full Text] [Related]

  • 26. Conversion from MCI to AD in patients with the APOE ε4 genotype: Prediction by plasma HCY and serum BDNF.
    Zheng L, Kong X, Cui Y, Wei Y, Zhang J, Wei W.
    Neurosci Lett; 2016 Jul 28; 626():19-24. PubMed ID: 27180036
    [Abstract] [Full Text] [Related]

  • 27. Distribution and clinical impact of apolipoprotein E4 in subjective memory impairment and early mild cognitive impairment.
    Cho H, Kim YE, Chae W, Kim KW, Kim JW, Kim HJ, Na DL, Ki CS, Seo SW.
    Sci Rep; 2020 Aug 07; 10(1):13365. PubMed ID: 32770103
    [Abstract] [Full Text] [Related]

  • 28. News event memory in amnestic and non-amnestic MCI, heritable risk for dementia, and subjective memory complaints.
    Asp I, Cawley-Bennett ATJ, Frascino JC, Golshan S, Bondi MW, Smith CN.
    Neuropsychologia; 2024 Jul 04; 199():108887. PubMed ID: 38621578
    [Abstract] [Full Text] [Related]

  • 29. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
    Scarabino D, Broggio E, Gambina G, Maida C, Gaudio MR, Corbo RM.
    Am J Med Genet B Neuropsychiatr Genet; 2016 Dec 04; 171(8):1131-1138. PubMed ID: 27604972
    [Abstract] [Full Text] [Related]

  • 30. Apolipoprotein E ε4 Modulates Cognitive Profiles, Hippocampal Volume, and Resting-State Functional Connectivity in Alzheimer's Disease.
    Wang X, Wang J, He Y, Li H, Yuan H, Evans A, Yu X, He Y, Wang H.
    J Alzheimers Dis; 2015 Dec 04; 45(3):781-95. PubMed ID: 25624419
    [Abstract] [Full Text] [Related]

  • 31. Mortality in amnestic mild cognitive impairment: a prospective community study.
    Hunderfund AL, Roberts RO, Slusser TC, Leibson CL, Geda YE, Ivnik RJ, Tangalos EG, Petersen RC.
    Neurology; 2006 Nov 28; 67(10):1764-8. PubMed ID: 17130407
    [Abstract] [Full Text] [Related]

  • 32. Quantitative electroencephalography (qEEG), apolipoprotein A-I (APOA-I), and apolipoprotein epsilon 4 (APOE ɛ4) alleles for the diagnosis of mild cognitive impairment and Alzheimer's disease.
    Niu X, Wang Y, Zhang X, Wang Y, Shao W, Chen L, Yang Z, Peng D.
    Neurol Sci; 2024 Feb 28; 45(2):547-556. PubMed ID: 37673807
    [Abstract] [Full Text] [Related]

  • 33. The association between APOE genotype and memory dysfunction in subjects with mild cognitive impairment is related to age and Alzheimer pathology.
    Ramakers IH, Visser PJ, Aalten P, Bekers O, Sleegers K, van Broeckhoven CL, Jolles J, Verhey FR.
    Dement Geriatr Cogn Disord; 2008 Feb 28; 26(2):101-8. PubMed ID: 18617739
    [Abstract] [Full Text] [Related]

  • 34. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
    Viticchi G, Falsetti L, Vernieri F, Altamura C, Altavilla R, Luzzi S, Bartolini M, Provinciali L, Silvestrini M.
    J Alzheimers Dis; 2014 Feb 28; 41(2):401-10. PubMed ID: 24625799
    [Abstract] [Full Text] [Related]

  • 35. Double-blind crossover study of the cognitive effects of lorazepam in healthy apolipoprotein E (APOE)-epsilon4 carriers.
    Stonnington CM, Snyder PJ, Hentz JG, Reiman EM, Caselli RJ.
    J Clin Psychiatry; 2009 Oct 28; 70(10):1379-84. PubMed ID: 19573495
    [Abstract] [Full Text] [Related]

  • 36. APOE is a correlate of phenotypic heterogeneity in Alzheimer disease in a national cohort.
    Weintraub S, Teylan M, Rader B, Chan KCG, Bollenbeck M, Kukull WA, Coventry C, Rogalski E, Bigio E, Mesulam MM.
    Neurology; 2020 Feb 11; 94(6):e607-e612. PubMed ID: 31704790
    [Abstract] [Full Text] [Related]

  • 37. Long-acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer's disease dementia.
    Claxton A, Baker LD, Hanson A, Trittschuh EH, Cholerton B, Morgan A, Callaghan M, Arbuckle M, Behl C, Craft S.
    J Alzheimers Dis; 2015 Feb 11; 44(3):897-906. PubMed ID: 25374101
    [Abstract] [Full Text] [Related]

  • 38. Association between DCHS2 gene and mild cognitive impairment and Alzheimer's disease in an elderly Brazilian sample.
    Vieira RN, Ávila R, de Paula JJ, Cintra MT, de Souza RP, Nicolato R, Malloy-Diniz L, de Miranda DM, de Moraes EN, de Marco LA, Romano-Silva MA, Bicalho MA.
    Int J Geriatr Psychiatry; 2016 Dec 11; 31(12):1337-1344. PubMed ID: 26876984
    [Abstract] [Full Text] [Related]

  • 39. Beta-amyloid associated differential effects of APOE ε4 on brain metabolism in cognitively normal elderly.
    Yi D, Lee DY, Sohn BK, Choe YM, Seo EH, Byun MS, Woo JI.
    Am J Geriatr Psychiatry; 2014 Oct 11; 22(10):961-70. PubMed ID: 24495404
    [Abstract] [Full Text] [Related]

  • 40. Impact of APOE in mild cognitive impairment.
    Farlow MR, He Y, Tekin S, Xu J, Lane R, Charles HC.
    Neurology; 2004 Nov 23; 63(10):1898-901. PubMed ID: 15557508
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.